Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle (13743)

ARTG ID 13743

ARTG Name

MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle

Product name

MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle

ARTG Date

23 August 1991

Registration Type

Medicine

Therapeutic good type

Medicines

Ingredients

benserazide hydrochloride

levodopa

Licence category

RE

Licence status

A

Summary

Product Information

Consumer Medicine Information

Related information

MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle, Roche Products Pty Ltd, CON-1265

26 August 2024

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 26 August 2024 until 31 August 2025.
MADOPAR HBS 125 levodopa 100 mg and benserazide 25 mg capsule bottle, Roche Products Pty Ltd, CON-1386

11 July 2025

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 11 July 2025 until 31 March 2028.